Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Stopping Infliximab and Adalimumab Treatment in Patients with Crohn’s Disease and Ulcerative Colitis in Remission

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study of adalimumab and infliximab dose adjustment guided by fecal calprotectin monitoring in adolescents and young adults with Crohn’s disease or ulcerative colitis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium The Netherlands Spain
  • Study on the Safety and Effectiveness of Mesenchymal Stem Cells for Treating Intestinal Strictures in Crohn’s Disease Patients

    Recruiting

    2 1
    Investigated diseases:
    Belgium
  • Study on the Effectiveness of Infliximab, Ustekinumab, and Vedolizumab for Patients with Resistant Crohn’s Disease

    Recruiting

    2 1 1 1
    Investigated diseases:
    Poland
  • Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Austria Croatia Czechia France Germany Hungary +6
  • Study on Infliximab for Children with Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn’s Disease

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Croatia Czechia France Germany +8
  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated drugs:
    Belgium Bulgaria Czechia Denmark France Germany +8
  • Study on Transmural Healing in Patients with Moderate to Severe Crohn’s Disease Using Upadacitinib and Drug Combination

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Denmark France Germany Italy The Netherlands +2
  • Study on the Long-term Safety of Guselkumab for Children with Crohn’s Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium France Germany Italy Norway Poland +2